Loading...
Bruxism and psychotropic medications
Antoun Reyad, Ayman Girgis, Eriny Ayoub, Amin Mishriky, Raafat
Antoun Reyad, Ayman
Girgis, Eriny
Ayoub, Amin
Mishriky, Raafat
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2020-02-13
Submitted date
Alternative
Abstract
Mental Health Disorders including schizophrenia, bipolar and schizoaffective disorders are often treated using psychotropic medications with evidence that some of these medications such as antipsychotics could be associated with significant oral side-effects. In this comprehensive review, we examine the psychotropic medications mechanisms of action and their oral side-effects, with specific focus on psychotropic medications and bruxism as a major oral health complication with a negative impact on the quality of life of mental health sufferers, relevant to psychiatrists, dentists and general practitioners. Bruxism could be caused by the antipsychotics extrapyramidal side-effects through dopaminergic receptors. Bruxism as a side-effect of psychotropic medications could result in significant consequences to oral health such as tooth structure destruction and irreversible harm to the temporomandibular joint. The review findings could assist in understanding the aetiology of bruxism, establish appropriate management plan, while supporting psychiatrists and dentists to detect temporomandibular dysfunctions (TMD) such as bruxism.
Citation
Antoun Reyad, A., Girgis, E., Ayoub, A. and Mishriky, R. (2020) Bruxism and psychotropic medications, Progress in Neurology and Psychiatry, 24(1), pp. 31-35.
Publisher
Research Unit
DOI
PubMed ID
PubMed Central ID
Embedded videos
Additional Links
Type
Journal article
Language
en
Description
This is an accepted manuscript of an article published by Wiley in Progress in Neurology and Psychiatry on 13/02/2020, available online: https://wchh.onlinelibrary.wiley.com/doi/10.1002/pnp.560
The accepted version of the publication may differ from the final published version.
Series/Report no.
ISSN
1367-7543